BMS-214662
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BMS-214662, covering 2009-12-03 to 2013-02-01. Get the full timeline:
Most recent: Clinical Trial Update: BMS-214662 in Treating Patients With Advanced Solid Tumors [Phase 1]